A $54 billion pharmaceutical tie-up announced Friday is the latest in a string of big mergers that has pushed deal activity past the $2 trillion mark this year, growing at a pace not seen since 2007.
read more
A $54 billion pharmaceutical tie-up announced Friday is the latest in a string of big mergers that has pushed deal activity past the $2 trillion mark this year, growing at a pace not seen since 2007.
read more